Sign in Subscribe
Nanoparticles

Breakthrough in Gold Nanoparticles Research: Ephedra Extract as Biogenic Stabilizer

Strategic Insights

— 1 min read

Scientists at Yantaishan Hospital in Shandong, People's Republic of China, have discovered a novel method for synthesizing gold nanoparticles (Au NPs) using kaolin as the support material and ephedra flower extract as a biogenic stabilizer and reducing agent. This eco-friendly approach has been found to possess antioxidant and anti-ovarian cancer properties. Researchers believe that the bio-composite material may hold promise as a therapeutic agent for treating human ovarian cancer.

Key Takeaways:

  • Researchers developed a straightforward, efficient, and environmentally friendly method to synthesize gold nanoparticles (Au NPs) supported on kaolin using ephedra flower extract as a biogenic stabilizer and reducing agent.
  • The analysis of the Au NPs/Kaolin composite's structural properties was conducted using FE-SEM, TEM, EDX, and XRD assays.
  • The biological activity of the composite was evaluated through cytotoxicity tests using the MTT assay, revealing potential anti-ovarian cancer properties.
  • The ovarian cancer cell lines showed a dose-dependent decline in % cell viability, with IC50 values found to be 112, 250, 278, and 243 mg/mL, respectively.
  • The HUVEC cell line was used to evaluate the material's biocompatibility with normal cells.
  • The researchers concluded that the bio-composite material is promising for treating human ovarian cancer.

Statistics:

  • IC50 values for ovarian cancer cell lines: 112, 250, 278, and 243 mg/mL.
  • Dose-dependent decline in % cell viability: 100% at 0 mg/mL, decreasing to 50% at 100 mg/mL.
  • 100% biocompatibility of the material with normal cells (HUVEC).

Sources:

  • "Ephedra extract-mediated gold nanoparticles on Kaolin: A natural approach for reduction and stabilization, with evaluation of antioxidant and anti-ovarian cancer activities" (Journal of Science: Advanced Materials and Devices, 2025,10(2):100853).
  • Yantaishan Hospital (Department of Gynecology, People's Republic of China).
  • Elsevier (publisher of Journal of Science: Advanced Materials and Devices).

Read more